FUNCTIONAL OUTCOMES FOLLOWING TREATMENT FOR ADVANCED LARYNGEAL-CANCER- PART I - VOICE PRESERVATION IN ADVANCED LARYNGEAL-CANCER - PART II - LARYNGECTOMY REHABILITATION - THE STATE-OF-THE-ART IN THE VA SYSTEM
Re. Hillman et al., FUNCTIONAL OUTCOMES FOLLOWING TREATMENT FOR ADVANCED LARYNGEAL-CANCER- PART I - VOICE PRESERVATION IN ADVANCED LARYNGEAL-CANCER - PART II - LARYNGECTOMY REHABILITATION - THE STATE-OF-THE-ART IN THE VA SYSTEM, The Annals of otology, rhinology & laryngology, 107(5), 1998, pp. 2-27
This two-part investigation assessed functional outcomes related to co
mmunication (including amount of speech therapy), swallowing and eatin
g, and employment status for patients who received one of the two trea
tment modalities for advanced laryngeal cancer (stage III or IV laryng
eal squamous cell carcinoma) in Veterans Administration Cooperative St
udy #268. One hundred sixty-six patients were randomized to primary su
rgery (laryngectomy) and radiotherapy (RT), and 166 to induction chemo
therapy (CT) and RT. The first investigation dealt with examining and
comparing functional outcomes for patients in the two treatment arms o
f the main study. Results showed clearly that patients with advanced l
aryngeal cancer are better off from the standpoint of speech communica
tion if they can be treated for this disease without removal of the la
rynx. In contrast, there were few significant differences between pati
ent groups for other non-speech-related measures. The second investiga
tion focused on communication-related outcomes associated with the reh
abilitation of total laryngectomy patients. Results revealed that only
relatively small percentages of total laryngectomy patients (6%) deve
loped usable esophageal speech or remained nonvocal (8%), and that a m
ajority of patients ended up as users of artificial electrolarynx (55%
) or tracheoesophageal (31%) speech. The results from both investigati
ons are discussed with respect to factors that can influence the rehab
ilitation process and long-term outcome status of patients who are tre
ated for advanced laryngeal cancer with these two strategies.